Hui‐Hwa Chang

683 total citations
9 papers, 564 citations indexed

About

Hui‐Hwa Chang is a scholar working on Physiology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Hui‐Hwa Chang has authored 9 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Organic Chemistry and 6 papers in Epidemiology. Recurrent topics in Hui‐Hwa Chang's work include Lysosomal Storage Disorders Research (8 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Trypanosoma species research and implications (6 papers). Hui‐Hwa Chang is often cited by papers focused on Lysosomal Storage Disorders Research (8 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Trypanosoma species research and implications (6 papers). Hui‐Hwa Chang collaborates with scholars based in United States, Japan and Australia. Hui‐Hwa Chang's co-authors include Jianqiang Fan, Seiichi Ishii, Xiaoxiang Zhu, Shihong Li, Yoshitaka Ichikawa, Naoki Asano, Kayo Yasuda, Kunito Kawasaki, Scott C. Garman and David J. Lockhart and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Biochemical Journal.

In The Last Decade

Hui‐Hwa Chang

8 papers receiving 546 citations

Peers

Countries citing papers authored by Hui‐Hwa Chang

Since Specialization

Citations

This map shows the geographic impact of Hui‐Hwa Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Hwa Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Hwa Chang more than expected).

Fields of papers citing papers by Hui‐Hwa Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Hwa Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Hwa Chang. The network helps show where Hui‐Hwa Chang may publish in the future.

Co-authorship network of co-authors of Hui‐Hwa Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Hwa Chang. A scholar is included among the top collaborators of Hui‐Hwa Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Hwa Chang. Hui‐Hwa Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Migalastat HCl Reduces Globotriaosylsphingosine (Lyso-Gb3) in Fabry Transgenic Mice and in the Plasma of Fabry Patients 2013 ·PLoS ONE ·(unknown), Nastry Brignol, Hui‐Hwa Chang, Richie Khanna, Rebecca Soska, Maria Fuller, Sheela Sitaraman, Dominique P. Germain, Roberto Giugliani, Derralynn Hughes, Atul Mehta, Kathy Nicholls, Pol Boudes, David J. Lockhart, Kenneth J. Valenzano, Elfrida R. Benjamin	35
2	The pharmacological chaperone 1‐deoxygalactonojirimycin increases α‐galactosidase A levels in Fabry patient cell lines 2009 ·Journal of Inherited Metabolic Disease ·Benjamin Elias, John J. Flanagan, Adriane Schilling, Hui‐Hwa Chang, (unknown), Evan Katz, Xi Wu, C.W. Pine, Brandon A. Wustman, Robert J. Desnick, David J. Lockhart, Kenneth J. Valenzano	135
3	Preclinical Efficacy and Safety of 1-Deoxygalactonojirimycin in Mice for Fabry Disease 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Seiichi Ishii, Hui‐Hwa Chang, Hidekatsu Yoshioka, Tatsuo Shimada, Kazuaki Mannen, Yasunori Higuchi, (unknown), Jianqiang Fan	30
4	113. Identification of Fabry disease-causing mutations that are responsive to the pharmacological chaperone AT1001 2008 ·Molecular Genetics and Metabolism ·Xiaoyang Wu, (unknown), Evan Katz, Hui‐Hwa Chang, Sanghoon Shin, (unknown), Gary J. Murray, Raphael Schiffmann, Kenneth J. Valenzano, David J. Lockhart, Elfrida R. Benjamin	1
5	Mutant α-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin 2007 ·Biochemical Journal ·Seiichi Ishii, Hui‐Hwa Chang, Kunito Kawasaki, Kayo Yasuda, (unknown), Scott C. Garman, Jianqiang Fan	109
6	Hydrophilic iminosugar active‐site‐specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients 2006 ·FEBS Journal ·Hui‐Hwa Chang, Naoki Asano, Seiichi Ishii, Yoshitaka Ichikawa, Jianqiang Fan	111
7	Rational Design and Synthesis of Highly Potent β‐Glucocerebrosidase Inhibitors 2005 ·Angewandte Chemie International Edition ·Xiaoxiang Zhu, (unknown), Shihong Li, Hui‐Hwa Chang, Jianqiang Fan	89
8	Rational Design and Synthesis of Highly Potent β‐Glucocerebrosidase Inhibitors 2005 ·Angewandte Chemie ·Xiaoxiang Zhu, (unknown), Shihong Li, Hui‐Hwa Chang, Jianqiang Fan	36
9	Efficient and rapid purification of recombinant human α-galactosidase A by affinity column chromatography 2004 ·Protein Expression and Purification ·Kayo Yasuda, Hui‐Hwa Chang, (unknown), Seiichi Ishii, Jianqiang Fan	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact